Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 31
Filtrar
1.
BMC Microbiol ; 13: 187, 2013 Aug 07.
Artículo en Inglés | MEDLINE | ID: mdl-23924316

RESUMEN

BACKGROUND: We previously identified two hydrolyzable tannins, chebulagic acid (CHLA) and punicalagin (PUG) that blocked herpes simplex virus type 1 (HSV-1) entry and spread. These compounds inhibited viral glycoprotein interactions with cell surface glycosaminoglycans (GAGs). Based on this property, we evaluated their antiviral efficacy against several different viruses known to employ GAGs for host cell entry. RESULTS: Extensive analysis of the tannins' mechanism of action was performed on a panel of viruses during the attachment and entry steps of infection. Virus-specific binding assays and the analysis of viral spread during treatment with these compounds were also conducted. CHLA and PUG were effective in abrogating infection by human cytomegalovirus (HCMV), hepatitis C virus (HCV), dengue virus (DENV), measles virus (MV), and respiratory syncytial virus (RSV), at µM concentrations and in dose-dependent manners without significant cytotoxicity. Moreover, the natural compounds inhibited viral attachment, penetration, and spread, to different degrees for each virus. Specifically, the tannins blocked all these steps of infection for HCMV, HCV, and MV, but had little effect on the post-fusion spread of DENV and RSV, which could suggest intriguing differences in the roles of GAG-interactions for these viruses. CONCLUSIONS: CHLA and PUG may be of value as broad-spectrum antivirals for limiting emerging/recurring viruses known to engage host cell GAGs for entry. Further studies testing the efficacy of these tannins in vivo against certain viruses are justified.


Asunto(s)
Antivirales/farmacología , Benzopiranos/farmacología , Glucósidos/farmacología , Glicosaminoglicanos/metabolismo , Taninos Hidrolizables/farmacología , Receptores Virales/metabolismo , Virosis/virología , Internalización del Virus/efectos de los fármacos , Virus/efectos de los fármacos , Animales , Línea Celular , Relación Dosis-Respuesta a Droga , Humanos , Virosis/metabolismo , Fenómenos Fisiológicos de los Virus/efectos de los fármacos
2.
J Virol ; 85(9): 4386-98, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21307190

RESUMEN

Herpes simplex virus 1 (HSV-1) is a common human pathogen that causes lifelong latent infection of sensory neurons. Non-nucleoside inhibitors that can limit HSV-1 recurrence are particularly useful in treating immunocompromised individuals or cases of emerging acyclovir-resistant strains of herpesvirus. We report that chebulagic acid (CHLA) and punicalagin (PUG), two hydrolyzable tannins isolated from the dried fruits of Terminalia chebula Retz. (Combretaceae), inhibit HSV-1 entry at noncytotoxic doses in A549 human lung cells. Experiments revealed that both tannins targeted and inactivated HSV-1 viral particles and could prevent binding, penetration, and cell-to-cell spread, as well as secondary infection. The antiviral effect from either of the tannins was not associated with induction of type I interferon-mediated responses, nor was pretreatment of the host cell protective against HSV-1. Their inhibitory activities targeted HSV-1 glycoproteins since both natural compounds were able to block polykaryocyte formation mediated by expression of recombinant viral glycoproteins involved in attachment and membrane fusion. Our results indicated that CHLA and PUG blocked interactions between cell surface glycosaminoglycans and HSV-1 glycoproteins. Furthermore, the antiviral activities from the two tannins were significantly diminished in mutant cell lines unable to produce heparan sulfate and chondroitin sulfate and could be rescued upon reconstitution of heparan sulfate biosynthesis. We suggest that the hydrolyzable tannins CHLA and PUG may be useful as competitors for glycosaminoglycans in the management of HSV-1 infections and that they may help reduce the risk for development of viral drug resistance during therapy with nucleoside analogues.


Asunto(s)
Antivirales/metabolismo , Glicoproteínas/antagonistas & inhibidores , Glicosaminoglicanos/antagonistas & inhibidores , Herpesvirus Humano 1/efectos de los fármacos , Taninos Hidrolizables/metabolismo , Proteínas Virales/antagonistas & inhibidores , Internalización del Virus/efectos de los fármacos , Animales , Antivirales/aislamiento & purificación , Benzopiranos/aislamiento & purificación , Benzopiranos/metabolismo , Línea Celular , Chlorocebus aethiops , Glucósidos/aislamiento & purificación , Glucósidos/metabolismo , Herpesvirus Humano 1/fisiología , Humanos , Taninos Hidrolizables/aislamiento & purificación , Pruebas de Sensibilidad Microbiana , Terminalia/química , Ensayo de Placa Viral , Inactivación de Virus
3.
Artículo en Inglés | MEDLINE | ID: mdl-19808846

RESUMEN

Phyllanthus urinaria Linnea (Euphorbiaceae) is one of the traditional medicinal plants widely used by oriental people to treat various diseases. We have previously demonstrated that the acetone extract of P. urinaria inhibits herpes simplex virus type 2 (HSV-2) but not HSV-1 infection. In a continuing effort to clarify the antiviral mechanisms of P. urinaria, we isolated the pure compound excoecarianin from the whole plant of P. urinaria through acetone extraction, and investigated its anti-HSV-1 and HSV-2 activities. Our results indicated that excoecarianin protected Vero cells from HSV-2 but not HSV-1 infection, and its 50% inhibitory concentration (IC(50)) was 1.4 ± 0.1 µM. The antiviral effective concentration of excoecarianin did not affect the viability or the morphology of Vero cells. Although excoecarianin inhibited HSV-2 infection, the inhibitory effect, however, was most prominent when excoecarianin was concurrently added with the virus. Pretreatment of Vero cells with excoecarianin with removal of the drug prior to infection did not yield any antiviral effects, and the same observation was made for post viral entry treatment. Subsequent studies revealed that excoecarianin inactivated HSV-2 virus particles to prevent viral infection. A synergistic antiviral effect against HSV-2 was also observed when Vero cells were treated with a combination of acyclovir (ACV) and excoecarianin. These results suggested that excoecarianin merits to be further explored as an entry inhibitor against HSV-2 and could potentially be investigated for combinatorial drug treatment with nucleoside analogues such as ACV in therapeutic management of HSV-2 infection.

4.
J Sci Food Agric ; 91(15): 2777-84, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21725979

RESUMEN

BACKGROUND: Persistent activation of hepatic stellate cells (HSC-T6) has been known to cause liver fibrosis. In this study, our objective was to investigate the effects of chebulagic acid and chebulinic acid, two hydrolysable tannins of tropical almond (Terminalia chebula) fruits, on collagen synthesis and signal transduction in transforming growth factor-ß1-stimulated HSC-T6 cells. The expression of Smad2, Smad3, Smad4, collagen I(α1)/III, and plasminogen activator inhibitor 1 (PAI-1) mRNAs was determined by reverse-transcription polymerase chain reaction and their protein levels were assessed by western blotting. RESULTS: Results showed that chebulagic acid and chebulinic acid at 20 µmol L(-1) exhibited cytotoxic and anti-proliferative effects on HSC-T6 cells. They also significantly decreased the expression of Smd2, Smad3 and Smad4, and the synthesis of collagen, procollagen I (α1) and III, as well as suppressing the activation of PAI-1; these events consequently facilitated the resolution of fibrosis. CONCLUSION: These results indicate that both chebulagic acid and chebulinic acid possess antifibrotic activity, and their mechanism of action could be through the inhibition of the Smad pathway.


Asunto(s)
Benzopiranos/uso terapéutico , Colágeno/biosíntesis , Glucósidos/uso terapéutico , Células Estrelladas Hepáticas/efectos de los fármacos , Taninos Hidrolizables/uso terapéutico , Cirrosis Hepática/tratamiento farmacológico , Fitoterapia , Terminalia/química , Animales , Benzopiranos/farmacología , Western Blotting , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Colágeno Tipo I/biosíntesis , Colágeno Tipo III/biosíntesis , Citotoxinas/farmacología , Citotoxinas/uso terapéutico , Frutas , Glucósidos/farmacología , Taninos Hidrolizables/farmacología , Cirrosis Hepática/genética , Cirrosis Hepática/metabolismo , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Inhibidor 1 de Activador Plasminogénico/metabolismo , ARN Mensajero/metabolismo , Ratas , Transducción de Señal/efectos de los fármacos , Proteínas Smad Reguladas por Receptores/metabolismo , Factor de Crecimiento Transformador beta1
5.
Cancer Lett ; 248(2): 280-91, 2007 Apr 18.
Artículo en Inglés | MEDLINE | ID: mdl-16963181

RESUMEN

In this study, we first report the chemopreventive effect of rugosin E in human breast cancer cell line, MDA-MB-231. Treatment with rugosin E decreased the cell proliferation of MDA-MB-231 cells in a dose-dependent manner. Rugosin E treatment arrested MDA-MB-231 cells at G0/G1 phase. This effect was strongly associated with concomitant decrease in the level of cyclin D1, cyclin D2, cyclin E, cdk2, cdk4, and cdk6, and increase of p21/WAF1. In addition, rugosin E also induced apoptotic cell death. Rugosin E increased in the expression of Bax, Bak, and Bcl-Xs, but decreased the levels of Bcl-2 and Bcl-X(L), and subsequently triggered mitochondria apoptotic pathway (release of cytochrome c, activation of caspase-9, and caspase-3). In addition, pre-treatment of cells with caspase-9 inhibitor blocked rugosin E-induced cell proliferation and apoptosis, indicating caspase-9 activation was involved in rugosin E-mediated MDA-MB-231 cells apoptosis. Rugosin E inhibited the constitutively activated and inducible NF-kappaB in both its DNA-binding activity and transcriptional activity. Furthermore, rugosin E also inhibited the TNF-alpha-activated NF-kappaB-dependent reporter gene expression of cyclin D1, c-Myc, XIAP, Bcl-2, and Bcl-X(L) were all downregulated by rugosin E. Our results indicated that rugosin E inhibits the activation of NF-kappaB, and this may provide a molecular basis for drug development in the prevention and treatment of cancer by rugosin E.


Asunto(s)
Apoptosis/efectos de los fármacos , Neoplasias de la Mama/prevención & control , Taninos Hidrolizables/farmacología , FN-kappa B/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Western Blotting , Neoplasias de la Mama/metabolismo , Ciclo Celular/efectos de los fármacos , Proteínas de Ciclo Celular/efectos de los fármacos , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ensayo de Cambio de Movilidad Electroforética , Femenino , Humanos , FN-kappa B/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
6.
J Ethnopharmacol ; 110(3): 555-8, 2007 Apr 04.
Artículo en Inglés | MEDLINE | ID: mdl-17113739

RESUMEN

Phyllanthus urinaria Linnea (Euphorbiaceae) is a widely used traditional medicinal plant by oriental countries and has been reported to possess various biological activities. Previously, the acetone extract from Phyllanthus urinaria was found to inhibit herpes simplex virus (HSV) infection. In this study, geraniin and 1,3,4,6-tetra-O-galloyl-beta-D-glucose (1346TOGDG), both of which were isolated from the acetone extract of Phyllanthus urinaria, were examined for their activity against HSV-1 and HSV-2 in vitro. Results showed that geraniin actively suppressed HSV-2 infection, whereas 1346TOGDG effectively inhibited HSV-1 infection. The 50% inhibitory concentration (IC(50)) was 18.4+/-2.0 microM for geraniin against HSV-2 infection, and 19.2+/-4.0 microM for 1346TOGDG against HSV-1. No toxic effect towards the host cell was observed at the antiviral concentrations. In conclusion, geraniin and 1346TOGDG were found to inhibit HSV-1 and HSV-2 multiplication at different magnitudes of potency.


Asunto(s)
Antivirales/farmacología , Ácido Gálico/análogos & derivados , Glucósidos/farmacología , Herpes Simple/tratamiento farmacológico , Taninos Hidrolizables/farmacología , Monosacáridos/farmacología , Phyllanthus/química , Animales , Antivirales/efectos adversos , Antivirales/aislamiento & purificación , Chlorocebus aethiops , Relación Dosis-Respuesta a Droga , Ácido Gálico/efectos adversos , Ácido Gálico/aislamiento & purificación , Ácido Gálico/farmacología , Glucósidos/efectos adversos , Glucósidos/aislamiento & purificación , Herpesvirus Humano 1/efectos de los fármacos , Herpesvirus Humano 2/efectos de los fármacos , Taninos Hidrolizables/efectos adversos , Taninos Hidrolizables/aislamiento & purificación , Riñón/citología , Riñón/efectos de los fármacos , Riñón/virología , Medicina Tradicional de Asia Oriental , Monosacáridos/efectos adversos , Monosacáridos/aislamiento & purificación , Fitoterapia , Extractos Vegetales/química , Extractos Vegetales/farmacología , Plantas Medicinales/química , Células Vero
7.
J Med Microbiol ; 55(Pt 2): 201-206, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16434713

RESUMEN

Herpes simplex virus (HSV) is a ubiquitous organism that causes infections in human populations throughout the world. It causes a variety of diseases ranging in severity from mild to life-threatening. In this study, ent-epiafzelechin-(4alpha-->8)-epiafzelechin (EEE) extracted from the fresh leaves of Cassia javanica L. agnes de Wit (Leguminosae) was investigated for its in vitro anti-HSV-2 activity using XTT and plaque reduction assays. Results showed that EEE inhibited HSV-2 replication in a dose-dependent manner. The IC50 value was 83.8 +/- 10.9 and 166.8 +/- 12.9 microM for XTT and plaque reduction assays, respectively. EEE did not affect the viability and the proliferation of cells at antiviral concentrations. Mechanistic studies demonstrated that EEE prevented HSV-2 from penetrating the cell and also interfered with HSV-2 replication at the late stage of its life cycle. It also disturbed virus attachment but the inhibitory effect was minor. In summary, the conclusion of this study was that EEE exhibits various modes of action in suppressing HSV-2 multiplication.


Asunto(s)
Antivirales/farmacología , Cassia/química , Catequina/análogos & derivados , Herpesvirus Humano 2/efectos de los fármacos , Animales , Antivirales/química , Catequina/química , Catequina/farmacología , Chlorocebus aethiops , Relación Dosis-Respuesta a Droga , Medicamentos Herbarios Chinos/química , Herpesvirus Humano 2/fisiología , Hojas de la Planta/química , Células Vero , Replicación Viral/efectos de los fármacos
8.
Antiviral Res ; 67(1): 24-30, 2005 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15885815

RESUMEN

Phyllanthus urinaria Linnea (Euphorbiaceae) is one of the traditional medicinal plants that are widely applied by oriental people, especially by Chinese and Indian, to ameliorate various kinds of ailments. Many biological activities, including anti-hepatitis B virus, anti-Epstein-Barr virus and anti-retroviral reverse transcriptase, of P. urinaria have been reported, but not against herpes simplex virus (HSV). In this study, the anti-HSV-1 and HSV-2 activities of different solvents extracted from P. urinaria were investigated in vitro by plaque reduction assay. Results showed that acetone, ethanol and methanol extracts of P. urinaria inhibited HSV-2 but not HSV-1 infection. The 50% inhibitory concentration against HSV-2 infection (IC50) of acetone, ethanol and methanol extracts was 4.3 +/- 0.5, 5.0 +/ -0.4 and 4.0 +/- 0.9 mcg/ml, respectively. All three extracts showed no cytotoxic effect against Vero cells at concentrations of 10.0 mcg/ml or below. The time-of-addition study demonstrated that these three extracts were only effective when added during the HSV-2 infection which, therefore, suggested that they disturb the initial stage of HSV-2 infection. Furthermore, they can diminish virus infectivity without significantly affecting incubation time and temperature. Therefore, the acetone, ethanol and methanol extracts of P. urinaria were concluded to likely inhibit HSV-2 infection through disturbing the early stage of virus infection and through diminishing the virus infectivity.


Asunto(s)
Antivirales/farmacología , Medicamentos Herbarios Chinos/farmacología , Herpesvirus Humano 2/efectos de los fármacos , Phyllanthus/química , Acetona/química , Animales , Chlorocebus aethiops , Medicamentos Herbarios Chinos/química , Etanol/química , Herpesvirus Humano 2/patogenicidad , Humanos , Metanol/química , Pruebas de Sensibilidad Microbiana/métodos , Células Vero , Ensayo de Placa Viral
9.
J Biosci Bioeng ; 99(5): 466-72, 2005 May.
Artículo en Inglés | MEDLINE | ID: mdl-16233818

RESUMEN

Six diesel-degrading bacterial strains were isolated from oil-polluted sites located in central Taiwan. The floating activity of the isolates in an oil-supplemented liquid medium was monitored. Cell-surface hydrophobicity as well as cell-free and cell-residue emulsification activities were also investigated. Three isolates, identified as Gordonia alkanivorans CC-JG 39, Rhodococcus erythropolis CC-BC 04, and R. erythropolis CC-BC 11, were found to float and grow near the diesel layer on the surface. The other three isolates (namely, Comamonas testosteroni CC-CF3, Acinetobacter sp. CC-CF 5, and Sphingomonas yanoikuyae CC-CG 22) did not display floating activity, as they distributed uniformly in the liquid medium. Isolated cell walls of the floating strains appeared to settle at a lower sucrose density than the non-floating strains. The floating strains were also characterized by a higher cell-surface hydrophobicity and a higher cell-residue emulsification activity than the non-floating strains. In fact, the floating strains were thought to produce extracellular emulsifiers due to their higher supernatant emulsification activity than the non-floating strains. The floating activity of G. alkanivorans CC-JG 39 may be associated with the production of extracellular polymeric substances that formed an "air-bag" structure facilitating cell floating. The floating ability may also correlate with a high cellular hydrophobicity arising from unique cell wall compositions or cell-wall-bound surface active products.


Asunto(s)
Bacterias/crecimiento & desarrollo , Bacterias/aislamiento & purificación , Fenómenos Fisiológicos Bacterianos , Gasolina/microbiología , Bacterias/citología , Recuento de Colonia Microbiana , Interacciones Hidrofóbicas e Hidrofílicas , Movimiento (Física)
10.
Microbes Infect ; 6(8): 738-44, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15207820

RESUMEN

The purpose of this study was to investigate the in vitro antiviral properties of pterocarnin A, extracted from the bark of Pterocarya stenoptera (Juylandaceae). Results showed that pterocarnin A exhibited anti-herpes simplex virus (HSV) activity. It had a low selectivity index (SI) value and only possessed some level of cell cytotoxic effect at high antiviral concentrations. Mechanism studies demonstrated that pterocarnin A inhibited herpes simplex virus type 2 (HSV-2) from attaching and penetrating into cells. It also actively suppressed HSV-2 multiplication in Vero cells even when added 12 h after infection. This observation indicated that pterocarnin A affected the late stage(s) of HSV-2 infection cycle. Pterocarnin A also significantly reduced viral infectivity at high concentrations. From these observations, it was concluded that pterocarnin A suppressed both early and late in the replication cycle of HSV-2. The various modes of action of pterocarnin A in interfering with certain steps of viral infection thus merit further investigation.


Asunto(s)
Ácido Gálico/análogos & derivados , Ácido Gálico/farmacología , Glicósidos/farmacología , Herpesvirus Humano 2/efectos de los fármacos , Herpesvirus Humano 2/fisiología , Juglandaceae/química , Corteza de la Planta/química , Replicación Viral/efectos de los fármacos , Animales , Antivirales/farmacología , Chlorocebus aethiops , Ácido Gálico/toxicidad , Glicósidos/toxicidad , Extractos Vegetales/farmacología , Extractos Vegetales/toxicidad , Células Vero , Inactivación de Virus
11.
Antiviral Res ; 55(3): 447-55, 2002 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-12206882

RESUMEN

Casuarinin, a hydrolyzable tannin isolated from the bark of Terminalia arjuna Linn. (Combretaceae), was investigated for its antiviral activity on herpes simplex type 2 (HSV-2) in vitro. Results showed that the IC(50) of casuarinin in XTT and plaque reduction assays were 3.6+/-0.9 and 1.5+/-0.2 microM, respectively. The 50% cytotoxic concentration for cell growth (CC(50)) was 89+/-1 microM. Thus, the selectivity index (SI) (ratio of CC(50) to IC(50)) of casuarinin was 25 and 59 for XTT and plaque reduction assays, respectively. Casuarinin continued to exhibit antiviral activity even added 12 h after infection. During the attachment assay, casuarinin was shown to prevent the attachment of HSV-2 to cells. Furthermore, casuarinin also exhibited an activity in inhibiting the viral penetration. Interestingly, casuarinin was virucidal at a concentration of 25 microM, reducing viral titers up to 100,000-fold. This study concludes that casuarinin possesses anti-herpesvirus activity in inhibiting viral attachment and penetration, and also disturbing the late event(s) of infection.


Asunto(s)
Antivirales/farmacología , Herpesvirus Humano 2/efectos de los fármacos , Taninos Hidrolizables , Taninos/farmacología , Terminalia/química , Animales , Antivirales/química , Chlorocebus aethiops , Herpes Simple/virología , Herpesvirus Humano 2/patogenicidad , Herpesvirus Humano 2/fisiología , Corteza de la Planta/química , Plantas Medicinales , Taninos/aislamiento & purificación , Taninos/metabolismo , Células Vero , Ensayo de Placa Viral , Virión/fisiología
12.
Eur J Pharmacol ; 501(1-3): 41-8, 2004 Oct 06.
Artículo en Inglés | MEDLINE | ID: mdl-15464061

RESUMEN

In this study, the antiproliferative activity of prodelphinidin B-2 3, 3'-di-O-gallate (PB233'OG) isolated from the bark of Myrica rubra (Myricaceae) was investigated. The results showed that PB233'OG inhibited the proliferation of A549 by blocking cell cycle progression in the G0/G1 phase and inducing apoptosis. Enzyme-linked immunosorbent assay (ELISA) showed that the G0/G1 phase arrest is due to increase the expression of p21/WAF1. An enhancement in Fas/APO-1 and its two form ligands, membrane-bound Fas ligand (mFasL) and soluble Fas ligand (sFasL), might be responsible for the apoptotic effect induced by PB233'OG. Our study reports here for the first time that the induction of p21/WAF1 and activity of the Fas/Fas ligand apoptotic system may participate in the anti-proliferative activity of PB233'OG in A549 cells.


Asunto(s)
Antocianinas/farmacología , Antineoplásicos Fitogénicos/farmacología , Apoptosis/efectos de los fármacos , Ciclo Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Inhibidores de Crecimiento/farmacología , Myrica , Antocianinas/química , Antocianinas/uso terapéutico , Apoptosis/fisiología , Carcinoma/tratamiento farmacológico , Carcinoma/patología , Ciclo Celular/fisiología , Línea Celular Tumoral , Humanos , Corteza de la Planta , Extractos Vegetales/química , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico
13.
Antivir Chem Chemother ; 13(4): 223-9, 2002 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12495210

RESUMEN

Prodelphinidin B-2 3-O-gallate, a proanthocyanidin gallate isolated from green tea leaf, was investigated for its anti-herpes simplex virus type 2 properties in vitro. Prodelphinidin B-2 3'-O-gallate exhibited antiviral activity with IC50 of 5.0 +/-1.0 microM and 1.6 +/-0.3 pM for XTT and plaque reduction (PRA) assays, respectively. Cytotoxicity assay had shown that prodelphinidin B-2 3'-O-gallate possessed cytotoxic effect toward Vero cell at concentration higher than its IC50. The 50% cytotoxic concentration for cell growth (CC50) was 33.3 +/- 3.7 microM. Thus, the selectivity index (SI) (ratio of IC50 to CC50) for XTT assay and PRA was 6.7 and 20.8, respectively. Prodelphinidin B-2 3'-O-gallate significantly reduced viral infectivity at concentrations 10 microM or more. Result of time-of-addition studies suggested that prodelphinidin B-2 3'-O-gallate affected the late stage of HSV-2 infection. In addition, it was also shown to inhibit the virus from attaching and penetrating into the cell. Thus, prodelphinidin B-2 3'-O-gallate was concluded to possess antiviral activity with mechanism of inhibiting viral attachment and penetration, and disturbing the late stage of viral infection.


Asunto(s)
Antocianinas/farmacología , Antivirales/farmacología , Herpesvirus Humano 2/efectos de los fármacos , Proantocianidinas , Té/química , Animales , Antocianinas/química , Antivirales/química , Chlorocebus aethiops , Relación Dosis-Respuesta a Droga , Herpesvirus Humano 2/fisiología , Concentración 50 Inhibidora , Hojas de la Planta/química , Factores de Tiempo , Células Vero/efectos de los fármacos , Células Vero/virología , Ensayo de Placa Viral
14.
Life Sci ; 71(16): 1879-92, 2002 Sep 06.
Artículo en Inglés | MEDLINE | ID: mdl-12175703

RESUMEN

The aim of this study is to investigate the anticancer effect of aloe-emodin in two human liver cancer cell lines, Hep G2 and Hep 3B. We observed that aloe-emodin inhibited cell proliferation and induced apoptosis in both examined cell lines, but with different the antiproliferative mechanisms. In Hep G2 cells, aloe-emodin induced p53 expression and was accompanied by induction of p21 expression that was associated with a cell cycle arrest in G1 phase. In addition, aloe-emodin had a marked increase in Fas/APO1 receptor and Bax expression. In contrast, with p53-deficient Hep 3B cells, the inhibition of cell proliferation of aloe-emodin was mediated through a p21-dependent manner that did not cause cell cycle arrest or increase the level of Fas/APO1 receptor, but rather promoted aloe-emodin induced apoptosis by enhancing expression of Bax. These findings suggest that aloe-emodin may be useful in liver cancer prevention.


Asunto(s)
Aloe/química , Apoptosis/fisiología , Carcinoma Hepatocelular/patología , Emodina/farmacología , Genes p53/fisiología , Proteína Oncogénica p21(ras)/fisiología , Animales , Antraquinonas , Apoptosis/efectos de los fármacos , Apoptosis/genética , Western Blotting , Ciclo Celular/fisiología , División Celular/fisiología , Ensayo de Inmunoadsorción Enzimática , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Genes bcl-2/genética , Nucleosomas/química , Ratas , Receptores de Lipoproteína/biosíntesis , Receptores de Lipoproteína/genética , Células Tumorales Cultivadas , Receptor fas/metabolismo
15.
J Pharm Pharmacol ; 56(11): 1399-406, 2004 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-15525446

RESUMEN

Myrica rubra Sieb et Zucc. (Myricaceae) is well known as a rich source of tannins. Prodelphinidin B-2 3,3'-di-O-gallate (PB233'OG) is a proanthocyanidin gallate that has been reported to exhibit antioxidant and antiviral activity. In this study, we evaluated the anti-proliferative activity of PB233'OG isolated from the bark of M. rubra in human breast adenocarcinoma MCF-7 cells. To identity the anti-cancer mechanism of PB233'OG, we assayed its effect on apoptosis, cell cycle distribution, and levels of p53, p21/WAF1, Fas/APO-1 receptor and Fas ligand. The results showed that PB233'OG induced apoptosis of MCF-7 cells without mediation of p53 and p21/WAF1. We suggest that Fas/Fas ligand apoptotic system is the main pathway of PB233'OG-mediated apoptosis of MCF-7 cells. Our study reports here for the first time that the activity of the Fas/Fas ligand apoptotic system may participate in the anti-proliferative activity of PB233'OG in MCF-7 cells.


Asunto(s)
Adenocarcinoma/patología , Antocianinas/farmacología , Apoptosis/efectos de los fármacos , Neoplasias de la Mama/patología , Myrica/química , Fitoterapia , Extractos Vegetales/farmacología , Ciclo Celular , Proteína Ligando Fas , Femenino , Humanos , Glicoproteínas de Membrana , , Células Tumorales Cultivadas , Receptor fas
16.
Int Immunopharmacol ; 15(1): 106-13, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23142091

RESUMEN

The hepatoprotective effects of an aqueous extract formula (AEF) derived from Artemisia capillaris, Lonicera japonica and Silybum marianum (ratio 1:1:1) were evaluated by its antioxidant properties and its attenuation of carbon tetrachloride (CCl(4))-induced liver damage in rats. The antioxidant analyses revealed that the AEF showed higher 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical and superoxide anion radical scavenging activities as well as ferric reducing antioxidant potential (FRAP) and Trolox equivalent antioxidant capacity (TEAC) compared with the individual herbs, suggesting a synergism in antioxidation between the three herbs. The animal experiments showed that the CCl(4) treatment increased serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities, but decreased triglyceride (TG) and glutathione (GSH) levels as well as glutathione peroxidase (GPx), superoxide dismutase (SOD) and catalase (CAT) activities. However, AEF administration can successfully lower serum ALT and AST activities, restore the GSH level, ameliorate or restore GPx and CAT activities as well as improve SOD action depending on AEF dosage. Histological examination of liver showed that CCl(4) increased the extent of bile duct proliferation, necrosis, fibrosis and fatty vacuolation throughout the liver, but AEF can improve bile duct proliferation, vacuolation and fibrosis, and restore necrosis. The present study demonstrated the hepatoprotective potential of AEF as an alternative to the traditional silymarin.


Asunto(s)
Antioxidantes/uso terapéutico , Artemisia , Enfermedad Hepática Inducida por Sustancias y Drogas/tratamiento farmacológico , Medicamentos Herbarios Chinos/uso terapéutico , Lonicera , Silybum marianum , Alanina Transaminasa/sangre , Animales , Aspartato Aminotransferasas/sangre , Tetracloruro de Carbono , Catalasa/metabolismo , Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Quimioterapia Combinada , Glutatión/metabolismo , Glutatión Peroxidasa/metabolismo , Masculino , Fitoterapia , Ratas , Ratas Sprague-Dawley , Superóxido Dismutasa/metabolismo , Triglicéridos/sangre
17.
Environ Sci Pollut Res Int ; 18(9): 1487-96, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21538227

RESUMEN

PURPOSE: Bioaugmentation and biostimulation have been widely applied in the remediation of oil contamination. However, ambiguous results have been reported. It is important to reveal the controlling factors on the field for optimal selection of remediation strategy. In this study, an integrated field landfarming technique was carried out to assess the relative effectiveness of five biological approaches on diesel degradation. The limiting factors during the degradation process were discussed. METHOD: A total of five treatments were tested, including conventional landfarming, nutrient enhancement (NE), biosurfactant addition (BS), bioaugmentation (BA), and combination of bioaugmentation and biosurfactant addition (BAS). The consortium consisted of four diesel-degrading bacteria strains. Rhamnolipid was used as the biosurfactant. The diesel concentration, bacterial population, evolution of CO(2), and bacterial community in the soil were periodically measured. RESULTS: The best overall degradation efficiency was achieved by BAS treatment (90 ± 2%), followed by BA (86 ± 2%), NE (84 ± 3%), BS (78 ± 3%), and conventional landfarming (68 ± 3%). In the early stage, the total petroleum hydrocarbon was degraded 10 times faster than the degradation rates measured during the period from day 30 to 100. At the later stage, the degradation rates were similar among treatments. In the conventional landfarming, contaminated soil contained bacteria ready for diesel degradation. CONCLUSION: The availability of hydrocarbon was likely the limiting factor in the beginning of the degradation process. At the later stage, the degradation was likely limited by desorption and mass transfer of hydrocarbon in the soil matrix.


Asunto(s)
Gasolina/análisis , Microbiología del Suelo , Contaminantes del Suelo/metabolismo , Biodegradación Ambiental , Bioensayo , Biomasa , Monitoreo del Ambiente/métodos , Contaminación Ambiental , Glucolípidos/metabolismo , Cinética , Modelos Lineales , Consorcios Microbianos , Análisis por Matrices de Proteínas/métodos
18.
J Hazard Mater ; 176(1-3): 27-34, 2010 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-20053499

RESUMEN

An innovative bioprocess method, Systematic Environmental Molecular Bioremediation Technology (SEMBT) that combines bioaugmentation and biostimulation with a molecular monitoring microarray biochip, was developed as an integrated bioremediation technology to treat S- and T-series biopiles by using the landfarming operation and reseeding process to enhance the bioremediation efficiency. After 28 days of the bioremediation process, diesel oil (TPH(C10-C28)) and fuel oil (TPH(C10-C40)) were degraded up to approximately 70% and 63% respectively in the S-series biopiles. When the bioaugmentation and biostimulation were applied in the beginning of bioremediation, the microbial concentration increased from approximately 10(5) to 10(6) CFU/g dry soil along with the TPH biodegradation. Analysis of microbial diversity in the contaminated soils by microarray biochips revealed that Acinetobacter sp. and Pseudomonas aeruginosa were the predominant groups in indigenous consortia, while the augmented consortia were Gordonia alkanivorans and Rhodococcus erythropolis in both series of biopiles during bioremediation. Microbial respiration as influenced by the microbial activity reflected directly the active microbial population and indirectly the biodegradation of TPH. Field experimental results showed that the residual TPH concentration in the complex biopile was reduced to less than 500 mg TPH/kg dry soil. The above results demonstrated that the SEMBT technology is a feasible alternative to bioremediate the oil-contaminated soil.


Asunto(s)
Biodegradación Ambiental , Petróleo/metabolismo , Contaminantes del Suelo/metabolismo , Monitoreo del Ambiente/instrumentación , Estudios de Factibilidad , Análisis por Micromatrices , Microbiología del Suelo , Tecnología
19.
Phytother Res ; 21(12): 1182-6, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17661333

RESUMEN

Phyllanthus urinaria Linnea (Euphorbiaceae) is a commonly used traditional medicinal plant in oriental countries and has been reported to possess various biological activities. Previously, the acetone extract and some pure compounds from P. urinaria were found to suppress herpes simplex virus (HSV). In this study, another two pure compounds were isolated from acetone extract of P. urinaria and were tested for their in vitro anti-HSV-1 and HSV-2 activities. The results showed that hippomanin A impeded HSV-2 but not HSV-1 infection. Corilagin, however, inhibited neither HSV-1 nor HSV-2 replication. The similarity between corilagin and hippomanin A in structure, but difference in antiviral activity, therefore, merit further investigation.


Asunto(s)
Glucósidos/farmacología , Herpesvirus Humano 1/efectos de los fármacos , Herpesvirus Humano 2/efectos de los fármacos , Phyllanthus/química , Antivirales/análisis , Antivirales/farmacología , Glucósidos/aislamiento & purificación , Taninos Hidrolizables , Extractos Vegetales/química , Extractos Vegetales/farmacología
20.
Anticancer Drugs ; 18(5): 555-62, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17414624

RESUMEN

Pterocarnin A, isolated from the bark of Pterocarya stenoptera (Juylandaceae), was investigated for its antiproliferative activity in human breast adenocarcinoma MCF-7 cells. To identify the anticancer mechanism of pterocarnin A, we assayed its effects on apoptosis, cell cycle distribution, and levels of p53, p21/WAF1, Fas/APO-1 receptor and Fas ligand. The results showed that pterocarnin A induced apoptosis of MCF-7 cells without mediation of p53 and p21/WAF1. We suggest that the Fas/Fas ligand apoptotic system is the main pathway of pterocarnin A-mediated apoptosis of MCF-7 cells. Our study reports here for the first time that the activity of the Fas/Fas ligand apoptotic system may participate in the antiproliferative activity of pterocarnin A in MCF-7 cells.


Asunto(s)
Adenocarcinoma/tratamiento farmacológico , Antineoplásicos Fitogénicos/farmacología , Apoptosis/efectos de los fármacos , Neoplasias de la Mama/tratamiento farmacológico , Proteína Ligando Fas/fisiología , Ácido Gálico/análogos & derivados , Glicósidos/farmacología , Juglandaceae/química , Adenocarcinoma/patología , Western Blotting , Neoplasias de la Mama/patología , Caspasa 8/metabolismo , Ciclo Celular/efectos de los fármacos , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Ensayo de Inmunoadsorción Enzimática , Ácido Gálico/farmacología , Genes p53/genética , Humanos , Proteína Oncogénica p21(ras)/genética , Corteza de la Planta/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA